{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:46:45Z","timestamp":1779270405683,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.revmed.2017.06.025","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T05:00:12Z","timestamp":1504846812000},"page":"731-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Microangiopathies thrombotiques secondaires"],"prefix":"10.1016","volume":"38","author":[{"given":"P.","family":"Coppo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2017.06.025_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review","volume":"166","author":"Abildgaard","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature06951","article-title":"Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia","volume":"453","author":"Kanasaki","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2017.06.025_bib0015","doi-asserted-by":"crossref","first-page":"477 47e1","DOI":"10.1016\/j.ajog.2010.06.011","article-title":"Steroid profiling in preeclamptic women: evidence for aromatase deficiency","volume":"203","author":"Hertig","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2017.06.025_bib0025","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.06.025_bib0030","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0035","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2017.06.025_bib0045","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.06.025_bib0050","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC","volume":"99","author":"de Fontbrune","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2017.06.025_bib0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.12202","article-title":"Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy","volume":"161","author":"Peffault de Latour","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","article-title":"Cancer awareness in atypical thrombotic microangiopathies","volume":"14","author":"Oberic","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2017.06.025_bib0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2015.02.340","article-title":"Thrombotic microangiopathy, cancer, and cancer drugs","volume":"66","author":"Izzedine","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2017.06.025_bib0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0032-1328894","article-title":"Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)","volume":"38","author":"Jacob","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.revmed.2017.06.025_bib0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.23720","article-title":"Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange","volume":"89","author":"Miller","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2008.02143.x","article-title":"R\u00e9seau d'\u00e9tude des microangiopathies thrombotiques (TMA-rare diseases reference center): human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity","volume":"68","author":"Malak","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2004.05325.x","article-title":"Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy","volume":"128","author":"Novitzky","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2017.06.025_bib0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.revmed.2011.11.015","article-title":"[Human immunodeficiency virus-associated thrombotic microangiopathies]","volume":"33","author":"Gilardin","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.06.025_bib0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.revmed.2015.10.354","article-title":"[Telemedicine in thrombotic microangiopathies: a way forward in rare diseases requiring emergency care]","volume":"37","author":"Coppo","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.06.025_bib0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.revmed.2014.10.364","article-title":"[The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy]","volume":"36","author":"Sauv\u00e8tre","year":"2015","journal-title":"Rev Med Interne"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317305763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317305763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:38:35Z","timestamp":1759336715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866317305763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0248866317305763"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2017.06.025","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microangiopathies thrombotiques secondaires","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2017.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}